A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis

It has been reported that overactivation of fibroblast growth factor receptor 1 (FGFR1) is an important characteristic found in most non-small cell lung cancer (NSCLC) samples. Here, we identified a FGFR1 inhibitory peptide R1-P2 and investigated its effects on the lung cancer cells growth and angio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Biol Sci
Egile Nagusiak: Tan, Qiaoyan, Wang, Zuqiang, Wang, Quan, Wang, Yuanqiang, Huang, Zhifeng, Su, Nan, Jin, Min, Kuang, Liang, Qi, Huabing, Ni, Zhenhong, Li, Can, Zhu, Ying, Jiang, Wanling, Chen, Hangang, Deng, Chuxia, Du, Xiaolan, Xie, Yangli, Chen, Lin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2018
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097486/
https://ncbi.nlm.nih.gov/pubmed/30123084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.24739
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak